Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2002
10/31/2002US20020160387 Compositions and methods relating to ovary specific genes and proteins
10/31/2002US20020160384 Polypeptides; binding to antibodies
10/31/2002US20020160383 Use of nucleic acid analogues in diagnostics and analytical procedures
10/31/2002US20020160374 Fusion protein; genetic engineering; binding to antibodies
10/31/2002US20020160358 Binding with ligand; calibrating deactivation
10/31/2002US20020160024 Modulating movement of a cell within or to the skin of a mammal by administering to mammal an effective amount of an antagonist an agonist of CTACK, an antagonist or agonist of Vic chemokines
10/31/2002US20020160015 Chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes and its uses
10/31/2002US20020160014 Cancer immunotherapy, particularly with immunotherapeutic combinations and treatment methods to prevent tumor cell growth and/or to eliminate those cells
10/31/2002US20020160010 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions
10/31/2002US20020160009 For treatment of disseminated candidiasis due to infection by C. albicans; composition includes phosphomannan of C. albicans
10/31/2002US20020160006 Methods of treating lymphoma and leukemia
10/31/2002US20020160005 Administering Shiga toxin or Shiga-like toxoid I or II as antigen to transgenic mouse having human genes, inducing immune response in mouse, isolating splenocytes from mouse following immune response, fusing splenocytes to myeloma cells
10/31/2002US20020160003 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability
10/31/2002US20020160002 SseCKS gene encodes a substrate of protein kinase C that functions as both a mitogenic regulator as well as a tumor suppressor
10/31/2002US20020160001 That accompanies subarachnoid hemorrhage comprising administering as treatment or prevention an agent that inhibits vascular cell proliferation
10/31/2002US20020160000 PD-1, a receptor for B7-4, and uses therefor
10/31/2002US20020159999 Administering donor peripheral blood progenitor cells to recipient and administering a non-chronic course of an immunosuppressant, e.g., cyclosporine
10/31/2002US20020159998 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
10/31/2002US20020159997 For passive immunization of patients infected with or susceptible to infection from Staphylococcus bacteria such as S.aureus and S.epidermidis
10/31/2002US20020159996 Use of CD23 antagonists for the treatment of neoplastic disorders
10/31/2002US20020159993 Immortal cell line derived from grouper epinephelus coioides and its applications therein
10/31/2002US20020159971 Methods and compositions for preventing and treating neutrophil-mediated diseases
10/31/2002US20020159958 Methods for producing immunoglobulins containing protection proteins in plants and their use
10/31/2002DE10118452A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid
10/31/2002CA2483507A1 Enzyme and snp marker for disease
10/31/2002CA2445255A1 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002CA2445197A1 T1r3 a novel taste receptor
10/31/2002CA2445179A1 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002CA2445168A1 Human timp-1 antibodies
10/31/2002CA2444706A1 Isolation of neural stem cells using gangliosides and other surface markers
10/31/2002CA2444691A1 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002CA2444680A1 Binding molecules for fc-region polypeptides
10/31/2002CA2444675A1 Secreted proteins
10/31/2002CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene
10/31/2002CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002CA2441540A1 Replikin peptides and uses thereof
10/31/2002CA2439693A1 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002CA2438833A1 Lactic acid bacteria as agents for treating and preventing allergy
10/31/2002CA2429351A1 A novel human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/30/2002EP1252895A1 Remedies for ophthalmic diseases
10/30/2002EP1252519A2 Methods for detecting cancer of the central nervous system
10/30/2002EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002EP1252318A2 Allene oxide cyclase gene and use thereof for producing jasmonic acid
10/30/2002EP1252311A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels
10/30/2002EP1252309A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
10/30/2002EP1252305A2 Full-length human cdnas encoding potentially secreted proteins
10/30/2002EP1252303A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252302A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252300A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
10/30/2002EP1252298A2 Phosphodiesterases
10/30/2002EP1252297A1 Nucleic acids, proteins, and antibodies
10/30/2002EP1252290A1 Nucleic acids, proteins, and antibodies
10/30/2002EP1252289A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252192A2 Enhancing the circulating half-life of antibody-based fusion proteins
10/30/2002EP1252191A1 Antibodies to suberic acid crosslinkers and methods for using the same
10/30/2002EP1252190A1 Antibodies specific for proteins having polyglutamine expansions
10/30/2002EP1252189A2 Novel human nucleic acid molecules and polypeptides encoding cation channels
10/30/2002EP1252188A2 G-protein coupled receptors
10/30/2002EP1252187A2 Fil-1 theta dnas and polypeptides
10/30/2002EP1252185A1 Nucleic acids, proteins, and antibodies
10/30/2002EP1252176A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1251873A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases
10/30/2002EP1251872A1 Compositions and methods for treating cell proliferation disorders
10/30/2002EP1140973A4 Protein-protein interactions in neurodegenerative disorders
10/30/2002EP1057024A4 Methods using pla 2? as a marker of metastases and for the diagnosis of selected cancers
10/30/2002EP1047942A4 Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
10/30/2002EP1017412A4 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
10/30/2002EP1000172A4 Detection of targets with green fluorescent protein and fluorescent variants thereof
10/30/2002EP0689552B1 A method of detecting rupture of the amniotic membranes in pregant mammals
10/30/2002CN1377411A BASB 119 polypeptide and polynucleotide from noraxella catarrhalis
10/30/2002CN1377410A Nucleic acids and proteins from group B streptoccus
10/30/2002CN1377408A The PRV-1 gene and use thereof
10/30/2002CN1377369A Vaccine antigens of moraxella
10/30/2002CN1377280A Diagnosis and treatment of neuroectodermal tumors
10/30/2002CN1377278A Prevention and treatment of amyloidogenic disease
10/30/2002CN1376796A Coding sequence of novel human protein and its preparing process and application
10/30/2002CN1376795A Calmative peptide precursor gene of dark-chest wasp, polypeptide coded by it and its preparing process
10/30/2002CN1376794A Hemolytic peptide precursor gene of Asian-African wasp aptoxin, polypeptide coded by it and its preparing process
10/30/2002CN1376791A Polypeptide-5-phosphate D-ribulose 3-isomerase-25.08 and polynucleotide for coding it
10/30/2002CN1376790A Polypeptide-topoisomerase-18.48 and polynucleotide for coding it
10/30/2002CN1376789A Polypeptide-human phosphotriesterase -22 and polynucleotide for coding it
10/30/2002CN1376788A Polypeptide-human tyrosine phosphatase -20.68 and polynucletoide for coding it
10/30/2002CN1376787A Polypeptide-tyrosine protein kinase -58.32 and polynucleotide for coding it
10/30/2002CN1376786A Polypeptide-human Ser/Thr protein kinase -36.08 and polynucletoide for coding it
10/30/2002CN1376785A Polypeptide-thiamine pyrophosphate kinase -26.73 and polynucleotide for coding it
10/30/2002CN1376784A Polypeptide-acetylgucosamine transferase GNT1-30.36 and polynucletoide for coding it
10/30/2002CN1376782A Polypeptide-human histidine deacetylase-14.96 and polynucelotide for coding it
10/30/2002CN1376781A Polypeptide-pyruvate phosphodehydrogenase -69.30 and polynucleotide for coding it
10/30/2002CN1376780A Polypeptide-threonine synthetase-9.35 and polynucleotide for coding it
10/30/2002CN1376716A Polypeptide-human macro protein-136.84 and polynucleotide for coding it
10/30/2002CN1376715A Polypeptide-human acanthotic microtubule bindin-93.36 and polynucleotide for coding it
10/30/2002CN1376714A Polypeptide-human macro protein -91.74 and polynucleotide for coding it
10/30/2002CN1376713A Polypeptide-olfactory receptor protein -9.25 and polynucleotide for coding it
10/30/2002CN1376712A Polypeptide-human zinc finger protein -44.11 and polynucleotide for coding it
10/30/2002CN1376711A Polypeptide-human Na ion and H ion exchange protein -60.72 and polynucleotide for coding it
10/30/2002CN1376710A Polypeptide-human non-hertone precursor -19.14 and polynucleotide for coding it
10/30/2002CN1376709A Polypeptide-human skin-specific protein -27.5 and polynucleotide for coding it
10/30/2002CN1376708A Polypeptide-immunoglobulin -25.63 and polynucleotide for coding it
10/30/2002CN1376707A Polypeptide-human zinc finger protein -35.09 and polynucleotide for coding it
10/30/2002CN1376706A Polypeptide-human macro protein -28.71 and polynucleotide for coding it
1 ... 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 ... 1494